The separation of the Diabetes business into a new public company, MiniMed, represents a significant strategic shift for Medtronic to focus on its core portfolios. This major transaction involves separating operations, systems, and personnel, creating potential needs for new standalone IT, finance, and HR solutions for both entities.
Filing excerpt
In May 2025, the Company announced its intent to separate the Diabetes Business, with the intention to create a new independent, publicly traded company, MiniMed Group, Inc. (MiniMed).
What this signalsFilings often name leadership changes, deals and spending plans.
sec-10kspinoffGet every 10-K signal for Medtronic and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Medtronic this week?”
The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/2450713e-7c56-41e9-b9cb-327c03523a86 returns this record as JSON. POST /v1/companies/enrich returns every signal for medtronic.com.
{
"signal_id": "2450713e-7c56-41e9-b9cb-327c03523a86",
"signal_type": "sec-10k",
"signal_subtype": "spinoff",
"detected_at": "2026-06-23T07:10:36.466+00:00",
"company": {
"name": "Medtronic",
"domain": "medtronic.com"
},
"data": {
"detail": "The separation of the Diabetes business into a new public company, MiniMed, represents a significant strategic shift for Medtronic to focus on its core portfolios. This major transaction involves separating operations, systems, and personnel, creating potential needs for new standalone IT, finance, and HR solutions for both entities.",
"metrics": {
"timeframe": "current_year"
},
"summary": "Medtronic completed spinoff of its Diabetes Business into MiniMed Group in March 2026.",
"excerpts": "In May 2025, the Company announced its intent to separate the Diabetes Business, with the intention to create a new independent, publicly traded company, MiniMed Group, Inc. (MiniMed).",
"relevance": 0.9,
"sentiment": "neutral",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/1613103/000162828026044354/mdt-20260424.htm",
"filing_date": "2026-06-18",
"filing_year": 2026,
"fiscal_year_end": "04/24",
"sales_relevance": "New entity needs vendors",
"signal_category": "strategic"
}
}
curl https://signals.autobound.ai/v1/signals/2450713e-7c56-41e9-b9cb-327c03523a86 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"medtronic.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.